Our Clinical and Analytical Steering Committee (CASC) is an international team of experts providing advice and guidance on a range of clinical and analytical issues. They help to shape the Oncology Data Network (ODN) initiative and ensure that information generated via the Network is appropriately interpreted and of value to the oncology community.
The Clinical and Analytical Steering Committee also governs how the ODN analyses are made available to the broader oncology community. If you are interested in learning more about how to access insights from the ODN, please click on the link below.
The CASC is committed to working openly and transparently. CASC members receive honoraria and travel expenses for their time and participation. Honoraria are provided by IQVIA in line with the pharmaceutical industry code of conduct guidelines, as set out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and in line with individual country guidelines.
‘The only way to understand the degree of variation in front-line cancer care – and enable development of strategies to iron out inconsistencies and inequalities – is to come together and share data in a structured, systematic way.’